Market Overview The global transarterial chemoembolization market is experiencing robust growth driven by hepatocellular carcinoma disease burden expansion, TACE emergence as a standard intermediate-stage HCC treatment, and technological innovation improving treatment efficacy and safety profiles. The global TACE market is projected to exceed USD 3 billion through 2030, fueled by HCC...